SB-681323

DRUG4 trials

Sponsors

GlaxoSmithKline

Conditions

Arthritis, RheumatoidCoronary Heart DiseaseInflammation

Phase 1

A Study To Look At The Safety Of SB-681323 In Healthy Adult Subjects After Intravenous Administration Of A Single Dose

CompletedNCT00439881

GlaxoSmithKlineArthritis, Rheumatoid, Inflammation

Start: 2006-10-31Target: 16Updated: 2012-06-04

Phase 2

A Single Dose Of Compound SB-681323 Compared To Prednisolone On A Protein That Is an Indicator For Rheumatoid Arthritis

CompletedNCT00134693

GlaxoSmithKlineArthritis, Rheumatoid

Start: 2005-06-21End: 2006-08-03Updated: 2017-07-31

A Pharmacokinetic Study Of SB-681323 In Subjects With Coronary Heart Disease Undergoing Percutaneous Intervention

CompletedNCT00291902

GlaxoSmithKlineCoronary Heart Disease

Start: 2006-03-31Target: 80Updated: 2012-06-04

SB-681323 In Subjects With Rheumatoid Arthritis

CompletedNCT00320450

GlaxoSmithKlineArthritis, Rheumatoid

Start: 2005-11-30End: 2006-10-31Updated: 2013-11-04